1.Lai Y, Di Nardo A, Nakatsuji T, Leichtle A, Yang Y, Cogen AL, et al.   Commensal bacteria regulate toll-like receptor 3-dependent inflammation after skin injury. Nat Med. 2009;15:1377–82.

2.Harrison OJ, Linehan JL, Shih HY, Bouladoux N, Han SJ, Smelkinson M, et al.   Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury. Science. 2019;363:eaat6280. https://doi.org/10.1126/science.aat6280.

3.Di Domizio J, Belkhodja C, Chenuet P, Fries A, Murray T, Mondéjar PM, et al.   The commensal skin microbiota triggers type I IFN-dependent innate repair responses in injured skin. Nat Immunol. 2020;21:1034–45.

4.Wang G, Sweren E, Liu H, Wier E, Alphonse MP, Chen R, et al.   Bacteria induce skin regeneration via IL-1β signaling. Cell Host Microbe. 2021;29:777–791.e6.

5.Naik S, Bouladoux N, Linehan JL, Han SJ, Harrison OJ, Wilhelm C, et al.   Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature. 2015;520:104–8.

6.Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, et al.   Topographical and temporal diversity of the human skin microbiome. Science. 2009;324:1190–2.

7.Findley K, Oh J, Yang J, Conlan S, Deming C, Meyer JA, et al.   Topographic diversity of fungal and bacterial communities in human skin. Nature. 2013;498:367–70.

8.Foulongne V, Sauvage V, Hebert C, Dereure O, Cheval J, Gouilh MA, et al.   Human skin microbiota: high diversity of DNA viruses identified on the human skin by high throughput sequencing. PLoS One. 2012;7:e38499.

9.Wylie KM, Mihindukulasuriya KA, Zhou Y, Sodergren E, Storch GA, Weinstock GM. Metagenomic analysis of double-stranded DNA viruses in healthy adults. BMC Biol. 2014;12:71.

10.Hannigan GD, Meisel JS, Tyldsley AS, Zheng Q, Hodkinson BP, SanMiguel AJ, et al.   The human skin double-stranded DNA virome: topographical and temporal diversity, genetic enrichment, and dynamic associations with the host microbiome. MBio. 2015;6:e01578–15.

11.Graham EH, Clarke JL, Fernando SC, Herr JR, Adamowicz MS. The application of the skin virome for human identification. Forensic Sci Int Genet. 2022;57:102662.

12.Oh J, Byrd AL, Park M, Kong HH, Segre JA. Temporal stability of the human skin microbiome. Cell. 2016;165:854–66.

13.Mueller NT, Bakacs E, Combellick J, Grigoryan Z, Dominguez-Bello MG. The infant microbiome development: mom matters. Trends Mol Med. 2015;21:109–17.

14.Marples RR, Downing DT, Kligman AM. Control of free fatty acids in human surface lipids by Corynebacterium acnes. J Invest Dermatol.  1971;56:127–31.

15.Gribbon EM, Cunliffe WJ, Holland KT. Interaction of Propionibacterium acnes with skin lipids in vitro. J Gen Microbiol. 1993;139:1745–51.

16.Aly R, Shirley C, Cunico B, Maibach HI. Effect of prolonged occlusion on the microbial flora, pH, carbon dioxide and transepidermal water loss on human skin. J Invest Dermatol. 1978;71:378–81.

17.Ying S, Zeng DN, Chi L, Tan Y, Galzote C, Cardona C, et al.   The influence of age and gender on skin-associated microbial communities in urban and rural human populations. PLoS One. 2015;10:e0141842.

18.Nakatsuji T, Chiang HI, Jiang SB, Nagarajan H, Zengler K, Gallo RL. The microbiome extends to subepidermal compartments of normal skin. Nat Commun. 2013;4:1431.

19.Bay L, Barnes CJ, Fritz BG, Thorsen J, Restrup MEM, Rasmussen L, et al.   Universal dermal microbiome in human skin. MBio. 2020;11:e02945–19. https://doi.org/10.1128/mBio.02945-19.

20.Prast-Nielsen S, Tobin AM, Adamzik K, Powles A, Hugerth LW, Sweeney C, et al.   Investigation of the skin microbiome: swabs vs. biopsies. Br J Dermatol. 2019;181:572–9.

21.Harris-Tryon TA, Grice EA. Microbiota and maintenance of skin barrier function. Science. 2022;376:940–5.

22.Naik S, Bouladoux N, Wilhelm C, Molloy MJ, Salcedo R, Kastenmuller W, et al.   Compartmentalized control of skin immunity by resident commensals. Science. 2012;337:1115–9.

23.Gallo RL, Hooper LV. Epithelial antimicrobial defence of the skin and intestine. Nat Rev Immunol. 2012;12:503–16.

24.Nakatsuji T, Chen TH, Narala S, Chun KA, Two AM, Yun T, et al.   Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med. 2017;9:eaah4680. https://doi.org/10.1126/scitranslmed.aah4680.

25.Laborel-Préneron E, Bianchi P, Boralevi F, Lehours P, Fraysse F, Morice-Picard F, et al.   Effects of the Staphylococcus aureus and Staphylococcus epidermidis Secretomes isolated from the skin microbiota of atopic children on CD4+ T cell activation. PLoS One. 2015;10:e0141067.

26.Linehan JL, Harrison OJ, Han SJ, Byrd AL, Vujkovic-Cvijin I, Villarino AV, et al.   Non-classical immunity controls microbiota impact on skin immunity and tissue repair. Cell. 2018;172:784–796.e18.

27.Nicoll MP, Proença JT, Efstathiou S. The molecular basis of herpes simplex virus latency. FEMS Microbiol Rev. 2012;36:684–705.

28.Vella V, Galgani I, Polito L, Arora AK, Creech CB, David MZ, et al.   Staphylococcus aureus skin and soft tissue infection recurrence rates in outpatients: a retrospective database study at 3 US medical Centers. Clin Infect Dis. 2021;73:e1045–53.

29.Nakamura Y, Oscherwitz J, Cease KB, Chan SM, Muñoz-Planillo R, Hasegawa M, et al.   Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. Nature. 2013;503:397–401.

30.Chang HW, Yan D, Singh R, Liu J, Lu X, Ucmak D, et al.   Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization. Microbiome. 2018;6:154.

31.Bantz SK, Zhu Z, Zheng T. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. J Clin Cell Immunol. 2014;05:202. https://doi.org/10.4172/2155-9899.1000202.

32.Ubags ND, Trompette A, Pernot J, Nibbering B, Wong NC, Pattaroni C, et al.   Microbiome-induced antigen-presenting cell recruitment coordinates skin and lung allergic inflammation. J Allergy Clin Immunol. 2021;147:1049–1062.e7.

33.Yu J, Oh MH, Park JU, Myers AC, Dong C, Zhu Z, et al.   Epicutaneous exposure to staphylococcal superantigen enterotoxin B enhances allergic lung inflammation via an IL-17A dependent mechanism. PLoS One. 2012;7:e39032.

34.Patrick GJ, Liu H, Alphonse MP, Dikeman DA, Youn C, Otterson JC, et al.   Epicutaneous Staphylococcus aureus induces IL-36 to enhance IgE production and ensuing allergic disease. J Clin Invest. 2021;131:e143334. https://doi.org/10.1172/jci143334.

35.Wang Y, Gao H, Loyd CM, Fu W, Diaconu D, Liu S, et al.   Chronic skin-specific inflammation promotes vascular inflammation and thrombosis. J Invest Dermatol.  2012;132:2067–75.

36.Evensen K, Slevolden E, Skagen K, Rønning OM, Brunborg C, Krogstad AL, et al.   Increased subclinical atherosclerosis in patients with chronic plaque psoriasis. Atherosclerosis. 2014;237:499–503.

37.Golden JB, Wang Y, Fritz Y, Diaconu D, Zhang X, Debanne SM, et al.   Chronic, not acute, skin-specific inflammation promotes thrombosis in psoriasis murine models. J Transl Med. 2015;13:382.

38.Hurabielle C, Link VM, Bouladoux N, Han SJ, Merrill ED, Lightfoot YL, et al.   Immunity to commensal skin fungi promotes psoriasiform skin inflammation. Proc Natl Acad Sci U S A. 2020;117:16465–74.

39.Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453:314–21.

40.Clark RAF. Wound repair: overview and general considerations. The molecular biology of wound repair. The Moleclar and Cellular Biology of Wound Repair. New York and London:Plenum Press, 1996, 3–50.

41.Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007;127:514–25.

42.Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18:1028–40.

43.Pastar I, Nusbaum AG, Gil J, Patel SB, Chen J, Valdes J, et al.   Interactions of methicillin resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in polymicrobial wound infection. PLoS One. 2013;8:e56846.

44.Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16:585–601.

45.Reinke JM, Sorg H. Wound repair and regeneration. Eur Surg Res. 2012;49:35–43.

46.Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3:349–63.

47.Sadtler K, Estrellas K, Allen BW, Wolf MT, Fan H, Tam AJ, et al.   Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells. Science. 2016;352:366–70.

48.Rani M, Schwacha MG. The composition of T-cell subsets are altered in the burn wound early after injury. PLoS One. 2017;12:e0179015.

49.Desmoulière A, Badid C, Bochaton-Piallat ML, Gabbiani G. Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int J Biochem Cell Biol. 1997;29:19–30.

50.Greenhalgh DG. The role of apoptosis in wound healing. Int J Biochem Cell Biol. 1998;30:1019–30.

51.Gill SE, Parks WC. Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol. 2008;40:1334–47.

52.Plichta JK, Gao X, Lin H, Dong Q, Toh E, Nelson DE, et al.   Cutaneous burn injury promotes shifts in the bacterial microbiome in autologous donor skin: implications for skin grafting outcomes. Shock. 2017;48:441–8.

53.Lima KM, Davis RR, Liu SY, Greenhalgh DG, Tran NK. Longitudinal profiling of the burn patient cutaneous and gastrointestinal microbiota: a pilot study. Sci Rep. 2021;11:10667.

54.Liu SH, Huang YC, Chen LY, Yu SC, Yu HY, Chuang SS. The skin microbiome of wound scars and unaffected skin in patients with moderate to severe burns in the subacute phase. Wound Repair Regen. 2018;26:182–91.

55.Bartow-McKenney C, Hannigan GD, Horwinski J, Hesketh P, Horan AD, Mehta S, et al.   The microbiota of traumatic, open fracture wounds is associated with mechanism of injury. Wound Repair Regen. 2018;26:127–35.

56.Hannigan GD, Hodkinson BP, McGinnis K, Tyldsley AS, Anari JB, Horan AD, et al.   Culture-independent pilot study of microbiota colonizing open fractures and association with severity, mechanism, location, and complication from presentation to early outpatient follow-up. J Orthop Res. 2014;32:597–605.

57.Ashrafi M, Xu Y, Muhamadali H, White I, Wilkinson M, Hollywood K, et al.   A microbiome and metabolomic signature of phases of cutaneous healing identified by profiling sequential acute wounds of human skin: an exploratory study. PLoS One. 2020;15:e0229545.

58.Chellan G, Neethu K, Varma AK, Mangalanandan TS, Shashikala S, Dinesh KR, et al.   Targeted treatment of invasive fungal infections accelerates healing of foot wounds in patients with type 2 diabetes. Diabet Med. 2012;29:e255–62.

59.Warkentien TE, Shaikh F, Weintrob AC, Rodriguez CJ, Murray CK, Lloyd BA, et al.   Impact of Mucorales and other invasive Molds on clinical outcomes of Polymicrobial traumatic wound infections. J Clin Microbiol. 2015;53:2262–70.

60.Lewandowski LR, Weintrob AC, Tribble DR, Rodriguez CJ, Petfield J, Lloyd BA, et al.   Early complications and outcomes in combat injury-related invasive fungal wound infections: a case-control analysis. J Orthop Trauma. 2016;30:e93–9.

61.Wanke I, Steffen H, Christ C, Krismer B, Götz F, Peschel A, et al.   Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol. 2011;131:382–90.

62.Zhang M, Jiang Z, Li D, Jiang D, Wu Y, Ren H, et al.   Oral antibiotic treatment induces skin microbiota dysbiosis and influences wound healing. Microb Ecol. 2015;69:415–21.

63.Canesso MC, Vieira AT, Castro TB, Schirmer BG, Cisalpino D, Martins FS, et al.   Skin wound healing is accelerated and scarless in the absence of commensal microbiota. J Immunol. 2014;193:5171–80.

64.Cogen AL, Yamasaki K, Sanchez KM, Dorschner RA, Lai Y, MacLeod DT, et al.   Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol.  2010;130:192–200.

65.Pastar I, O'Neill K, Padula L, Head CR, Burgess JL, Chen V, et al.   Staphylococcus epidermidis boosts innate immune response by activation of Gamma Delta T cells and induction of Perforin-2 in human skin. Front Immunol. 2020;11:550946.

66.Rademacher F, Simanski M, Hesse B, Dombrowsky G, Vent N, Gläser R, et al.   Staphylococcus epidermidis activates aryl hydrocarbon receptor Signaling in human keratinocytes: implications for cutaneous Defense. J Innate Immun. 2019;11:125–35.

67.Luqman A, Muttaqin MZ, Yulaipi S, Ebner P, Matsuo M, Zabel S, et al.   Trace amines produced by skin bacteria accelerate wound healing in mice. Commun Biol. 2020;3:277.

68.Zheng Y, Hunt RL, Villaruz AE, Fisher EL, Liu R, Liu Q, et al.   Commensal Staphylococcus epidermidis contributes to skin barrier homeostasis by generating protective ceramides. Cell Host Microbe. 2022;30:301–313.e9.

69.Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al.   Expert consensus document. The international scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506–14.

70.Mohammedsaeed W, Cruickshank S, McBain AJ, O'Neill CA. Lactobacillus rhamnosus GG lysate increases re-epithelialization of keratinocyte scratch assays by promoting migration. Sci Rep. 2015;5:16147.

71.Lopes EG, Moreira DA, Gullón P, Gullón B, Cardelle-Cobas A, Tavaria FK. Topical application of probiotics in skin: adhesion, antimicrobial and antibiofilm in vitro assays. J Appl Microbiol. 2017;122:450–61.

72.Chan AP, Choi Y, Brinkac LM, Krishnakumar R, DePew J, Kim M, et al.   Multidrug resistant pathogens respond differently to the presence of co-pathogen, commensal, probiotic and host cells. Sci Rep. 2018;8:8656.

73.Onbas T, Osmanagaoglu O, Kiran F. Potential properties of lactobacillus plantarum F-10 as a bio-control strategy for wound infections. Probiotics Antimicrob Proteins. 2019;11:1110–23.

74.Valdéz JC, Peral MC, Rachid M, Santana M, Perdigón G. Interference of lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment. Clin Microbiol Infect. 2005;11:472–9.

75.Satish L, Gallo PH, Johnson S, Yates CC, Kathju S. Local probiotic therapy with lactobacillus plantarum mitigates scar formation in rabbits after burn injury and infection. Surg Infect. 2017;18:119–27.

76.Olofsson TC, Butler É, Lindholm C, Nilson B, Michanek P, Vásquez A. Fighting off wound pathogens in horses with honeybee lactic acid bacteria. Curr Microbiol. 2016;73:463–73.

77.Argenta A, Satish L, Gallo P, Liu F, Kathju S. Local application of probiotic bacteria prophylaxes against sepsis and death resulting from burn wound infection. PLoS One. 2016;11:e0165294.

78.Oryan A, Alemzadeh E, Eskandari MH. Kefir accelerates burn wound healing through inducing fibroblast cell migration in vitro and modulating the expression of IL-1ß, TGF-ß1, and bFGF genes in vivo. Probiotics Antimicrob Proteins. 2019;11:874–86.

79.Han N, Jia L, Su Y, Du J, Guo L, Luo Z, et al.   Lactobacillus reuteri extracts promoted wound healing via PI3K/AKT/β-catenin/TGFβ1 pathway. Stem Cell Res Ther. 2019;10:243.

80.Li M, Xiao H, Su Y, Cheng D, Jia Y, Li Y, et al.   Synergistic inhibitory effect of honey and lactobacillus plantarum on pathogenic bacteria and their promotion of healing in infected wounds. Pathogens. 2023;12:501. https://doi.org/10.3390/pathogens12030501.

81.Rodrigues KL, Caputo LR, Carvalho JC, Evangelista J, Schneedorf JM. Antimicrobial and healing activity of kefir and kefiran extract. Int J Antimicrob Agents. 2005;25:404–8.

82.Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med. 2014;6:265sr6.

83.Kalan LR, Meisel JS, Loesche MA, Horwinski J, Soaita I, Chen X, et al.   Strain- and species-level variation in the microbiome of diabetic wounds is associated with clinical outcomes and therapeutic efficacy. Cell Host Microbe. 2019;25:641–655.e5.

84.Nussbaum SR, Carter MJ, Fife CE, DaVanzo J, Haught R, Nusgart M, et al.   An economic evaluation of the impact, cost, and Medicare policy implications of chronic nonhealing wounds. Value Health. 2018;21:27–32.

85.Versey Z, da  Cruz NWS, Russell E, Zigic S, DeZeeuw KG, Marek JE, et al.   Biofilm-innate immune Interface: contribution to chronic wound formation. Front Immunol. 2021;12:648554.

86.James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, et al.   Biofilms in chronic wounds. Wound Repair Regen. 2008;16:37–44.

87.Malone M, Bjarnsholt T, McBain AJ, James GA, Stoodley P, Leaper D, et al.   The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J Wound Care. 2017;26:20–5.

88.Schierle CF, De la Garza M, Mustoe TA, Galiano RD. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen. 2009;17:354–9.

89.Wolcott RD, Hanson JD, Rees EJ, Koenig LD, Phillips CD, Wolcott RA, et al.   Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing. Wound Repair Regen. 2016;24:163–74.

90.James GA, Ge Zhao A, Usui M, Underwood RA, Nguyen H, Beyenal H, et al.   Microsensor and transcriptomic signatures of oxygen depletion in biofilms associated with chronic wounds. Wound Repair Regen. 2016;24:373–83.

91.Nakagami G, Schultz G, Kitamura A, Minematsu T, Akamata K, Suga H, et al.   Rapid detection of biofilm by wound blotting following sharp debridement of chronic pressure ulcers predicts wound healing: a preliminary study. Int Wound J. 2020;17:191–6.

92.Roy S, Elgharably H, Sinha M, Ganesh K, Chaney S, Mann E, et al.   Mixed-species biofilm compromises wound healing by disrupting epidermal barrier function. J Pathol. 2014;233:331–43.

93.Roy S, Santra S, Das A, Dixith S, Sinha M, Ghatak S, et al.   Staphylococcus aureus biofilm infection compromises wound healing by causing deficiencies in granulation tissue collagen. Ann Surg. 2020;271:1174–85.

94.Dowd SE, Sun Y, Secor PR, Rhoads DD, Wolcott BM, James GA, et al.   Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol. 2008;8:43.

95.Misic AM, Gardner SE, Grice EA. The wound microbiome: modern approaches to examining the role of microorganisms in impaired chronic wound healing. Adv Wound Care (New Rochelle). 2014;3:502–10.

96.Rhoads DD, Wolcott RD, Sun Y, Dowd SE. Comparison of culture and molecular identification of bacteria in chronic wounds. Int J Mol Sci. 2012;13:2535–50.

97.Gardner SE, Hillis SL, Heilmann K, Segre JA, Grice EA. The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes. 2013;62:923–30.

98.Loesche M, Gardner SE, Kalan L, Horwinski J, Zheng Q, Hodkinson BP, et al.   Temporal stability in chronic wound microbiota is associated with poor healing. J Invest Dermatol.  2017;137:237–44.

99.Verbanic S, Shen Y, Lee J, Deacon JM, Chen IA. Microbial predictors of healing and short-term effect of debridement on the microbiome of chronic wounds. NPJ Biofilms Microbiomes. 2020;6:21.

100.Gardiner M, Vicaretti M, Sparks J, Bansal S, Bush S, Liu M, et al.   A longitudinal study of the diabetic skin and wound microbiome. PeerJ. 2017;5:e3543. https://doi.org/10.7717/peerj.3543.

101.Redel H, Gao Z, Li H, Alekseyenko AV, Zhou Y, Perez-Perez GI, et al.   Quantitation and composition of cutaneous microbiota in diabetic and nondiabetic men. J Infect Dis. 2013;207:1105–14.

102.Eckhard M, Lengler A, Liersch J, Bretzel R G, and Mayser P. Fungal foot infections in patients with diabetes mellitus--results of two independent investigations.  Mycoses  2007;50 :14–9. doi:

103.Chellan G, Shivaprakash S, Karimassery Ramaiyar S, Varma AK, Varma N, Thekkeparambil Sukumaran M, et al.   Spectrum and prevalence of fungi infecting deep tissues of lower-limb wounds in patients with type 2 diabetes. J Clin Microbiol. 2010;48:2097–102.

104.Dowd SE, Delton Hanson J, Rees E, Wolcott RD, Zischau AM, Sun Y, et al.   Survey of fungi and yeast in polymicrobial infections in chronic wounds. J Wound Care. 2011;20:40–7.

105.Kalan L, Loesche M, Hodkinson BP, Heilmann K, Ruthel G, Gardner SE, et al.   Redefining the chronic-wound microbiome: fungal communities are prevalent. Dynamic, and Associated with Delayed Healing mBio. 2016;7:e01058–16. https://doi.org/10.1128/mBio.01058-16.

106.Verbanic S, Deacon JM, Chen IA. The chronic wound Phageome: phage diversity and associations with wounds and healing outcomes. Microbiol Spectr. 2022;10:e0277721.

107.Kirker KR, Secor PR, James GA, Fleckman P, Olerud JE, Stewart PS. Loss of viability and induction of apoptosis in human keratinocytes exposed to Staphylococcus aureus biofilms in vitro. Wound Repair Regen. 2009;17:690–9.

108.Kirker KR, James GA, Fleckman P, Olerud JE, Stewart PS. Differential effects of planktonic and biofilm MRSA on human fibroblasts. Wound Repair Regen. 2012;20:253–61.

109.Ramirez HA, Pastar I, Jozic I, Stojadinovic O, Stone RC, Ojeh N, et al.   Staphylococcus aureus triggers induction of miR-15B-5P to diminish DNA repair and deregulate inflammatory response in diabetic foot ulcers. J Invest Dermatol.  2018;138:1187–96.

110.Pastar I, Sawaya AP, Marjanovic J, Burgess JL, Strbo N, Rivas KE, et al.   Intracellular Staphylococcus aureus triggers pyroptosis and contributes to inhibition of healing due to perforin-2 suppression. J Clin Invest. 2021;131:e133727. https://doi.org/10.1172/jci133727.

111.Strbo N, Pastar I, Romero L, Chen V, Vujanac M, Sawaya AP, et al.   Single cell analyses reveal specific distribution of anti-bacterial molecule Perforin-2 in human skin and its modulation by wounding and Staphylococcus aureus infection. Exp Dermatol. 2019;28:225–32.

112.Tomic-Canic M, Burgess JL, O'Neill KE, Strbo N, Pastar I. Skin microbiota and its interplay with wound healing. Am J Clin Dermatol. 2020;21:36–43.

113.Fazli M, Bjarnsholt T, Kirketerp-Møller K, Jørgensen B, Andersen AS, Krogfelt KA, et al.   Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J Clin Microbiol. 2009;47:4084–9.

114.Sweere JM, Ishak H, Sunkari V, Bach MS, Manasherob R, Yadava K, et al.   The immune response to chronic Pseudomonas aeruginosa wound infection in immunocompetent mice. Adv Wound Care (New Rochelle). 2020;9:35–47.

115.Jesaitis AJ, Franklin MJ, Berglund D, Sasaki M, Lord CI, Bleazard JB, et al.   Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol. 2003;171:4329–39.

116.Trøstrup H, Lerche CJ, Christophersen LJ, Thomsen K, Jensen P, Hougen HP, et al.   Chronic Pseudomonas aeruginosa biofilm infection impairs murine S100A8/A9 and neutrophil effector cytokines-implications for delayed wound closure?  Pathog Dis. 2017;75:1–10. https://doi.org/10.1093/femspd/ftx068.

117.Trøstrup H, Lerche CJ, Christophersen LJ, Thomsen K, Jensen P, Hougen HP, et al.   Pseudomonas aeruginosa biofilm hampers murine central wound healing by suppression of vascular epithelial growth factor. Int Wound J. 2018;15:123–32.

118.van der  Plas MJ, Bhongir RK, Kjellström S, Siller H, Kasetty G, Mörgelin M, et al.   Pseudomonas aeruginosa elastase cleaves a C-terminal peptide from human thrombin that inhibits host inflammatory responses. Nat Commun. 2016;7:11567.

119.D'Arpa P, Karna SLR, Chen T, Leung KP. Pseudomonas aeruginosa transcriptome adaptations from colonization to biofilm infection of skin wounds. Sci Rep. 2021;11:20632.

120.Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, et al.   Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature. 2010;465:346–9.

121.Bitschar K, Staudenmaier L, Klink L, Focken J, Sauer B, Fehrenbacher B, et al.   Staphylococcus aureus skin colonization is enhanced by the interaction of neutrophil extracellular traps with keratinocytes. J Invest Dermatol.  2020;140:1054–1065.e4.

122.Yang JJ, Chang TW, Jiang Y, Kao HJ, Chiou BH, Kao MS, et al.   Commensal Staphylococcus aureus provokes immunity to protect against skin infection of methicillin-resistant Staphylococcus aureus. Int J Mol Sci. 2018;19:1290. https://doi.org/10.3390/ijms19051290.

123.Alves PM, Al-Badi E, Withycombe C, Jones PM, Purdy KJ, Maddocks SE. Interaction between Staphylococcus aureus and Pseudomonas aeruginosa is beneficial for colonisation and pathogenicity in a mixed biofilm. Pathog Dis. 2018;76:1–10. https://doi.org/10.1093/femspd/fty003.

124.Orazi G, O'Toole GA. Pseudomonas aeruginosa alters Staphylococcus aureus sensitivity to vancomycin in a biofilm model of cystic fibrosis infection. MBio. 2017;8:e00873–17. https://doi.org/10.1128/mBio.00873-17.

125.Wollenberg MS, Claesen J, Escapa IF, Aldridge KL, Fischbach MA, Lemon KP. Propionibacterium-produced coproporphyrin III induces Staphylococcus aureus aggregation and biofilm formation. MBio. 2014;5:e01286–14.

126.Shu M, Wang Y, Yu J, Kuo S, Coda A, Jiang Y, et al.   Fermentation of Propionibacterium acnes, a commensal bacterium in the human skin microbiome, as skin probiotics against methicillin-resistant Staphylococcus aureus. PLoS One. 2013;8:e55380.

127.Ramsey MM, Freire MO, Gabrilska RA, Rumbaugh KP, Lemon KP. Staphylococcus aureus shifts toward commensalism in response to Corynebacterium species. Front Microbiol. 2016;7:1230.

128.Mottola C, Mendes JJ, Cristino JM, Cavaco-Silva P, Tavares L, Oliveira M. Polymicrobial biofilms by diabetic foot clinical isolates. Folia Microbiol (Praha). 2016;61:35–43.

129.Meneghin A, Hogaboam CM. Infectious disease, the innate immune response, and fibrosis. J Clin Invest. 2007;117:530–8.

130.Chioma OS, Drake WP. Role of microbial agents in pulmonary fibrosis. Yale J Biol Med. 2017;90:219–27.

131.Wu J, Del Duca E, Espino M, Gontzes A, Cueto I, Zhang N, et al.   RNA sequencing keloid transcriptome associates keloids with Th2, Th1, Th17/Th22, and JAK3-skewing. Front Immunol. 2020;11:597741.

132.Feng C, Shan M, Xia Y, Zheng Z, He K, Wei Y, et al.   Single-cell RNA sequencing reveals distinct immunology profiles in human keloid. Front Immunol. 2022;13:940645.

133.Agbenorkul PT, Kus H, Myczkowski T. The keloid triad hypothesis (KTH): a basis for keloid etiopathogenesis and clues for prevention. Eur J Plast Surg. 1995;18:301–4.

134.Alonso PE, Rioja LF, Pera C. Keloids: a viral hypothesis. Med Hypotheses. 2008;70:156–66.

135.Pratsinis H, Mavrogonatou E, Kletsas D. Scarless wound healing: from development to senescence. Adv Drug Deliv Rev. 2019;146:325–43.

136.Kong X, Fu J, Shao K, Wang L, Lan X, Shi J. Biomimetic hydrogel for rapid and scar-free healing of skin wounds inspired by the healing process of oral mucosa. Acta Biomater. 2019;100:255–69.

137.Frenard C, Dagnelie MA, Khammari A, Saint-Jean M, Boisrobert A, Corvec S, et al.   Do Cutibacterium acnes and Staphylococcus aureus define two different types of folliculitis?: bacteriological study of scalp folliculitis. J Eur Acad Dermatol Venereol. 2018;32:e266–8.

138.Singer AJ, McClain SA. Persistent wound infection delays epidermal maturation and increases scarring in thermal burns. Wound Repair Regen. 2002;10:372–7.

139.Bagabir RA, Syed F, Rautemaa R, McGrouther DA, Paus R, Bayat A. Upregulation of toll-like receptors (TLRs) 6, 7, and 8 in keloid scars. J Invest Dermatol.  2011;131:2128–30.

140.Arvia R, Margheri F, Stincarelli MA, Laurenzana A, Fibbi G, Gallinella G, et al.   Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis. Rheumatology (Oxford). 2020;59:3526–32.

141.Ashrafi M, Sebastian A, Shih B, Greaves N, Alonso-Rasgado T, Baguneid M, et al.   Whole genome microarray data of chronic wound debridement prior to application of dermal skin substitutes. Wound Repair Regen. 2016;24:870–5.

142.Kostarnoy AV, Gancheva PG, Logunov DY, Verkhovskaya LV, Bobrov MA, Scheblyakov DV, et al.   Topical bacterial lipopolysaccharide application affects inflammatory response and promotes wound healing. J Interf Cytokine Res. 2013;33:514–22.

143.Sahana TG, Rekha PD. A novel exopolysaccharide from marine bacterium Pantoea sp. YU16-S3 accelerates cutaneous wound healing through Wnt/β-catenin pathway. Carbohydr Polym. 2020;238:116191.

144.Simonetti O, Cirioni O, Cacciatore I, Baldassarre L, Orlando F, Pierpaoli E, et al.   Efficacy of the quorum sensing inhibitor FS10 alone and in combination with Tigecycline in an animal model of staphylococcal infected wound. PLoS One. 2016;11:e0151956.

145.O'Loughlin CT, Miller LC, Siryaporn A, Drescher K, Semmelhack MF, Bassler BL. A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation. Proc Natl Acad Sci U S A. 2013;110:17981–6.

146.Brackman G, Cos P, Maes L, Nelis HJ, Coenye T. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob Agents Chemother. 2011;55:2655–61.

147.Mookherjee N, Anderson MA, Haagsman HP, Davidson DJ. Antimicrobial host defence peptides: functions and clinical potential. Nat Rev Drug Discov. 2020;19:311–32.

148.Mangoni ML, McDermott AM, Zasloff M. Antimicrobial peptides and wound healing: biological and therapeutic considerations. Exp Dermatol. 2016;25:167–73.

149.Takahashi M, Umehara Y, Yue H, Trujillo-Paez JV, Peng G, Nguyen HLT, et al.   The antimicrobial peptide human β-Defensin-3 accelerates wound healing by promoting angiogenesis, cell migration, and proliferation through the FGFR/JAK2/STAT3 Signaling pathway. Front Immunol. 2021;12:712781.

150.Peral MC, Martinez MA, Valdez JC. Bacteriotherapy with lactobacillus plantarum in burns. Int Wound J. 2009;6:73–81.

151.Peral MC, Rachid MM, Gobbato NM, Huaman Martinez MA, Valdez JC. Interleukin-8 production by polymorphonuclear leukocytes from patients with chronic infected leg ulcers treated with lactobacillus plantarum. Clin Microbiol Infect. 2010;16:281–6.

152.Twetman S, Keller MK, Lee L, Yucel-Lindberg T, Pedersen AML. Effect of probiotic lozenges containing lactobacillus reuteri on oral wound healing: a pilot study. Benef Microbes. 2018;9:691–6.

153.Wälivaara D, Sjögren I, Gerasimcik N, Yucel-Lindberg T, Twetman S, Abrahamsson P. Effects of lactobacillus reuteri-containing lozenges on healing after surgical removal of mandibular third molars: a randomised controlled trial. Benef Microbes. 2019;10:653–9.

154.Vågesjö E, Öhnstedt E, Mortier A, Lofton H, Huss F, Proost P, et al.   Accelerated wound healing in mice by on-site production and delivery of CXCL12 by transformed lactic acid bacteria. Proc Natl Acad Sci U S A. 2018;115:1895–900.

155.Severn MM, Horswill AR. Staphylococcus epidermidis and its dual lifestyle in skin health and infection. Nat Rev Microbiol. 2022;21:97–111.

156.Matsuzaki S, Yasuda M, Nishikawa H, Kuroda M, Ujihara T, Shuin T, et al.   Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J Infect Dis. 2003;187:613–24.

157.Kering KK, Kibii BJ, Wei H. Biocontrol of phytobacteria with bacteriophage cocktails. Pest Manag Sci. 2019;75:1775–81.

158.Rhoads DD, Wolcott RD, Kuskowski MA, Wolcott BM, Ward LS, Sulakvelidze A. Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J Wound Care. 2009;18:237-8–40-3.

159.Ramasubbu N, Thomas LM, Ragunath C, Kaplan JB. Structural analysis of dispersin B, a biofilm-releasing glycoside hydrolase from the periodontopathogen Actinobacillus actinomycetemcomitans. J Mol Biol. 2005;349:475–86.

160.Qin Z, Ou Y, Yang L, Zhu Y, Tolker-Nielsen T, Molin S, et al.   Role of autolysin-mediated DNA release in biofilm formation of Staphylococcus epidermidis. Microbiology (Reading). 2007;153:2083–92.

161.Patel KK, Surekha DB, Tripathi M, Anjum MM, Muthu MS, Tilak R, et al.   Antibiofilm potential of silver sulfadiazine-loaded nanoparticle formulations: a study on the effect of DNase-I on microbial biofilm and wound healing activity. Mol Pharm. 2019;16:3916–25.

162.Percival SL, Kite P, Eastwood K, Murga R, Carr J, Arduino MJ, et al.   Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol. 2005;26:515–9.

163.Raad I, Chatzinikolaou I, Chaiban G, Hanna H, Hachem R, Dvorak T, et al.   In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother. 2003;47:3580–5.

164.Thapa RK, Winther-Larsen HC, Ovchinnikov K, Carlsen H, Diep DB, Tønnesen HH. Hybrid hydrogels for bacteriocin delivery to infected wounds. Eur J Pharm Sci. 2021;166:105990.

165.Reish RG, Eriksson E. Scar treatments: preclinical and clinical studies. J Am Coll Surg. 2008;206:719–30.

166.Agha R, Ogawa R, Pietramaggiori G, Orgill DP. A review of the role of mechanical forces in cutaneous wound healing. J Surg Res. 2011;171:700–8.

167.Chen YE, Fischbach MA, Belkaid Y. Skin microbiota-host interactions. Nature. 2018;553:427–36.

168.Grogan MD, Bartow-McKenney C, Flowers L, Knight SAB, Uberoi A, Grice EA. Research techniques made simple: profiling the skin microbiota. J Invest Dermatol.  2019;139:747–752.e1.